20
Mylan Laboratories Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is MAFENIDE ACETATE USP, with a corresponding US DMF Number 24615.
Remarkably, this DMF maintains an Active status since its submission on May 03, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 23, 2014, and payment made on December 19, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II